| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,141 |
7,630 |
$611K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,179 |
3,934 |
$431K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,300 |
5,027 |
$358K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,034 |
4,776 |
$249K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,490 |
1,444 |
$189K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,935 |
4,344 |
$134K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,516 |
2,466 |
$116K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,755 |
1,674 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,794 |
1,776 |
$47K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,072 |
1,869 |
$28K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
181 |
178 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
239 |
232 |
$5K |
| 87430 |
|
231 |
228 |
$3K |
| 99215 |
Prolong outpt/office vis |
44 |
44 |
$2K |
| 87807 |
|
114 |
104 |
$1K |
| 81025 |
|
82 |
76 |
$625.24 |
| 81002 |
|
188 |
176 |
$533.07 |
| 87400 |
|
32 |
16 |
$417.26 |
| 81003 |
|
211 |
194 |
$351.62 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
13 |
$60.50 |
| 99072 |
|
4,192 |
3,882 |
$57.82 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
14 |
12 |
$2.88 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$1.20 |